Tag: weight loss drugs

Market News

5 Must-Know Market Moves To Start Your Day Right

From Fed firings to AI lawsuits and Netflix's big screen splash, these market moves could shape your investments. What's next...

26/08/2025

2 views

Read More

Market News

Eli Lilly’s Obesity Pill: A New Weight Loss Contender

Eli Lilly’s new obesity pill could shake up the weight loss market, rivaling Novo Nordisk’s oral Wegovy. But what makes...

24/08/2025

2 views

Read More

Market News

Obesity Pill Setbacks: What Investors Need to Know

Viking Therapeutics' obesity pill trial data sent its stock plummeting 30%. What went wrong, and what does it mean for...

19/08/2025

2 views

Read More

Market News

Why Novo Nordisk’s GLP-1 Growth Is Slowing: Key Insights

Novo Nordisk’s Ozempic is losing ground in the GLP-1 market. What’s behind the slowdown, and can it recover? Dive into...

05/08/2025

10 views

Read More

Market News

Can Weight Loss Drugs Transform PCOS Treatment?

Could weight loss drugs like Wegovy revolutionize PCOS treatment? From regular periods to weight loss, discover the potential. Click to...

20/07/2025

2 views

Read More

Global Companies

Chinese Obesity Drug Challenges Eli Lilly’s Zepbound

A new Chinese obesity drug shows stunning results, rivaling Zepbound. Could this reshape the weight loss market? Click to find...

16/07/2025

2 views

Read More

Market News

Generic Semaglutide in Canada: Weight Loss Revolution

Hims & Hers brings generic semaglutide to Canada, promising affordable weight loss solutions. But how will this change lives? Click...

09/07/2025

2 views

Read More

Market News

Why McDonald’s Stock Is a Smart Buy Despite Downgrades

McDonald's stock faces downgrades, but is it a golden opportunity? Uncover why savvy investors are eyeing this dip. Click to...

10/06/2025

0 views

Read More

Smart Money

GLP-1 Drugs: How They Reshape Spending Habits

New survey reveals GLP-1 drug users are slashing restaurant budgets. How do these meds reshape lifestyles? Click to uncover surprising...

04/05/2025

1 views

Read More

Market News

Roche’s $5.3B Obesity Drug Deal Unveiled

Roche’s $5.3B bet on Zealand’s petrelintide could redefine obesity treatment. Will it outshine giants like Novo Nordisk? Click to uncover...

02/05/2025

0 views

Read More